MedPath

Cortical Visual Impairment and Visual Attentiveness

Not Applicable
Completed
Conditions
Cerebral Palsy
Cortical Visual Impairment
Interventions
Behavioral: cross-modal sensory stimulation
Registration Number
NCT00342108
Lead Sponsor
Sheba Medical Center
Brief Summary

This study will investigate the effect of enhanced visual and cross-modal environments upon the visual attentiveness of multiply handicapped children diagnosed with Cerebral Palsy (CP) and Cortical Visual Impairment (CVI).

Research Hypothesis

1. Adapted visual environments which present controlled auditory, tactile, proprioceptive or contrasting visual background stimulation will enhance the visual attentiveness to a given visual stimulus of children diagnosed with CP and CVI.

2. Systematic, repetitive, visual stimulation over time, improves the visual attentiveness and/or visual-motor responses of CP-CVI children.

3. The analysis of additional behavioral responses to visual stimuli is a critical component in evaluating the perceptual development of visual attention in CP-CVI children.

Use of Noldus: The Observer, an advanced objective computerized observation program, will enable precise detection of the neurobehavioral responses of the participants. Both overt and covert responses will be observed, analyzed and correlated to identify the level of attention of each participant.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • two to twelve years of age
  • diagnosis of: CP, mental retardation (MR) and CVI (Control group participants without visual disability)
Exclusion Criteria
  • N/A

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1cross-modal sensory stimulationDiagnosis: CP, moderate to severe MR and CVI
2cross-modal sensory stimulationDiagnosis: CP, Moderate to severe MR, no visual impairment
Primary Outcome Measures
NameTimeMethod
Eye Movementswithin the testing session
Secondary Outcome Measures
NameTimeMethod
Other behavioural responseswithin the testing session

Trial Locations

Locations (1)

Sheba_Medical_Center

🇮🇱

Ramat Gan, Israel

© Copyright 2025. All Rights Reserved by MedPath